Examine This Report on ADH-503
Given that Pirfenidone is metabolised in the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy would be to be prevented.We display that ADH-503 blunts the two monocyte and granulocyte trafficking, though at the same time specifically stimulating the anti-tumor Homes